Table 5.
Model | Parameters | Variable | Estimate | SD | 95% HPD interval |
---|---|---|---|---|---|
(x1, x2, x4, x5, x8, x9) | β | Disease | 0.130 | 0.034 | (0.062, 0.196) |
Age | 0.233 | 0.037 | (0.164, 0.308) | ||
Karnofprg | −0.090 | 0.032 | (−0.152, −0.028) | ||
Gsource | 0.062 | 0.037 | (−0.009, 0.136) | ||
Prevgvh11 | 0.127 | 0.063 | (0.008, 0.253) | ||
Prevgvh12 | 0.062 | 0.071 | (−0.071, 0.207) | ||
Prevgvh13 | 0.014 | 0.041 | (−0.067, 0.093) | ||
Prevgvh14 | 0.010 | 0.044 | (−0.076, 0.096) | ||
Cytoabnew1 | −0.424 | 0.109 | (−0.633, −0.206) | ||
Cytoabnew2 | −0.614 | 0.103 | (−0.812, −0.405) | ||
Cytoabnew3 | −0.726 | 0.205 | (−1.150, −0.342) | ||
α | Intercept 1 | −2.158 | 0.071 | (−2.302, −2.024) | |
Intercept 2 | −0.428 | 0.046 | (−0.518, −0.338) | ||
Intercept 3 | 2.950 | 0.097 | (2.754, 3.135) | ||
Disease | 0.363 | 0.043 | (0.275, 0.444) | ||
Age | 0.105 | 0.047 | (0.011, 0.194) | ||
Karnofprg | −0.073 | 0.043 | (−0.155, 0.011) | ||
Gsource | 0.144 | 0.046 | (0.056, 0.238) | ||
Prevgvh11 | −0.021 | 0.073 | (−0.159, 0.127) | ||
Prevgvh12 | −0.213 | 0.080 | (−0.367, −0.056) | ||
Prevgvh13 | 0.036 | 0.049 | (−0.058, 0.134) | ||
Prevgvh14 | −0.136 | 0.054 | (−0.245, −0.032) | ||
(x1, x2, x4, x5, x9) | β | Disease | 0.127 | 0.034 | (0.060, 0.195) |
Age | 0.235 | 0.037 | (0.163, 0.308) | ||
Karnofprg | −0.088 | 0.031 | (−0.151, −0.027) | ||
Gsource | 0.068 | 0.036 | (−0.004, 0.135) | ||
Cytoabnew1 | −0.423 | 0.108 | (−0.623, −0.200) | ||
Cytoabnew2 | −0.618 | 0.102 | (−0.809, −0.409) | ||
Cytoabnew3 | −0.743 | 0.204 | (−1.140, −0.351) | ||
α | Intercept 1 | −2.136 | 0.070 | (−2.277, −2.003) | |
Intercept 2 | −0.420 | 0.046 | (−0.508, −0.329) | ||
Intercept 3 | 2.928 | 0.096 | (2.743, 3.116) | ||
Disease | 0.353 | 0.043 | (0.269, 0.437) | ||
Age | 0.113 | 0.046 | (0.018, 0.198) | ||
Karnofprg | −0.069 | 0.042 | (−0.150, 0.014) | ||
Gsource | 0.149 | 0.045 | (0.063, 0.240) |